| Literature DB >> 20150646 |
Yoshiteru Miyajima1, Yuichi Sato, Hidehiro Oka, Satoshi Utsuki, Koji Kondo, Yoshinori Tanizaki, Ryo Nagashio, Benio Tsuchiya, Isao Okayasu, Kiyotaka Fujii.
Abstract
The present study was conducted to determine whether any correlation exists between the expression of DJ-1 and WHO grading of the tumor or patient prognosis, and to analyze the function of this oncogene in astrocytomas. Twenty-nine formalin-fixed and paraffin-embedded glioblastomas (grade IV), 21 anaplastic astorocytomas (grade III), and 14 diffuse astrocytomas (grade II) were immunohistochemically studied to identify the expression of DJ-1 protein. The expression of DJ-1 was detected both in the nucleus and cytoplasm of tumor cells; however, such expression varied from case to case. While there was no difference in the cytoplasmic expression of DJ-1 among astrocytomas, its nuclear expression was inversely correlated with the WHO grading of astrocytomas. Moreover, the overall survival of patients with maintained (group 1) or mixed (groups 2 and 3) was significantly longer than those with decreased (group 3) expression (p=0.0063). The present study demonstrated that the survival of patients with astrocytomas was correlated with the nuclear DJ-1 status of the tumor. We herein demonstrated for the first time that the DJ-1 molecule might therefore play an important role as a tumor suppressor in astrocytomas.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20150646
Source DB: PubMed Journal: Anticancer Res ISSN: 0250-7005 Impact factor: 2.480